tiprankstipranks
Trending News
More News >
Nuchev Pty Ltd (AU:NUC)
ASX:NUC
Australian Market

Nuchev Pty Ltd (NUC) AI Stock Analysis

Compare
2 Followers

Top Page

AU:NUC

Nuchev Pty Ltd

(Sydney:NUC)

Select Model
Select Model
Select Model
Underperform 38 (OpenAI - 4o)
Rating:38Underperform
Price Target:
AU$0.12
▼(-1.67% Downside)
Nuchev Pty Ltd's stock score is primarily impacted by its financial performance and valuation. The company's strong revenue growth is overshadowed by significant profitability and cash flow issues, leading to a low financial performance score. Technical analysis indicates a bearish trend with oversold conditions, which could be a potential buying opportunity if the stock reverses. The negative P/E ratio and lack of dividend yield further contribute to the low overall score.
Positive Factors
Revenue Growth
Strong revenue growth indicates increasing market demand and successful product adoption, which can drive future expansion and market share gains.
Low Debt Burden
A low debt burden enhances financial flexibility, reducing risk and allowing the company to invest in growth opportunities without significant financial strain.
Market Position
By offering premium, goat milk-based products, Nuchev capitalizes on health-conscious consumer trends, strengthening its niche market position.
Negative Factors
Profitability Challenges
Ongoing profitability issues could hinder reinvestment in the business and limit competitive capabilities, impacting long-term sustainability.
Cash Flow Issues
Negative cash flows can constrain operational capabilities and growth initiatives, necessitating improvements in cash management and operational efficiency.
Negative Return on Equity
Negative ROE indicates inefficiency in using shareholders' equity to generate profits, which could deter investment and affect long-term growth prospects.

Nuchev Pty Ltd (NUC) vs. iShares MSCI Australia ETF (EWA)

Nuchev Pty Ltd Business Overview & Revenue Model

Company DescriptionNuchev Pty Ltd (NUC) is an Australian-based company that specializes in the development and distribution of premium, goat milk-based nutritional products. Operating primarily in the infant formula and functional food sectors, Nuchev focuses on producing high-quality, natural alternatives to traditional cow's milk products. The company's core offerings include a range of infant formula, toddler milk, and other dietary supplements that cater to health-conscious consumers. Nuchev is committed to sustainability and ethical sourcing, ensuring that its products are not only nutritious but also environmentally friendly.
How the Company Makes MoneyNuchev Pty Ltd generates revenue primarily through the sale of its goat milk-based infant formula and related nutritional products. The company employs a direct-to-consumer sales model, alongside partnerships with retailers and distributors to expand its market reach. Key revenue streams include online sales through its own e-commerce platform and third-party retailers, as well as bulk sales to health food stores and supermarkets. Significant partnerships with health and wellness influencers and nutritionists also contribute to brand awareness and customer acquisition, driving sales growth. Additionally, Nuchev may benefit from strategic alliances with distributors that facilitate entry into international markets, thereby enhancing its revenue potential.

Nuchev Pty Ltd Financial Statement Overview

Summary
Nuchev Pty Ltd is experiencing strong revenue growth, but profitability and cash flow remain significant concerns. The company has a low debt burden, which is a positive aspect, but the negative return on equity and cash flow challenges highlight the need for operational improvements. Investors should be cautious and monitor the company's efforts to enhance profitability and cash flow.
Income Statement
35
Negative
Nuchev Pty Ltd has shown significant revenue growth of 45.28% in the latest year, indicating strong sales momentum. However, the company is struggling with profitability, as evidenced by negative net profit margins and EBIT margins. The gross profit margin is moderate, but the persistent negative EBIT and net income highlight ongoing operational challenges.
Balance Sheet
40
Negative
The company's debt-to-equity ratio is low, suggesting conservative leverage. However, the return on equity is negative, reflecting the company's inability to generate profits from its equity base. The equity ratio is relatively stable, indicating a solid asset base, but the negative ROE is a concern for investors.
Cash Flow
30
Negative
Nuchev Pty Ltd's cash flow situation is challenging, with negative operating and free cash flows. The free cash flow growth rate is negative, and the operating cash flow to net income ratio is unfavorable, indicating cash flow issues. The company needs to improve its cash generation to support its operations and growth.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue22.94M22.94M11.34M8.79M9.72M10.90M
Gross Profit10.86M10.86M3.63M1.90M2.78M3.20M
EBITDA-3.73M-3.73M-7.18M-8.57M-10.88M-12.40M
Net Income-3.82M-3.82M-7.32M-8.81M-11.11M-13.27M
Balance Sheet
Total Assets17.39M17.39M20.09M15.32M17.75M28.31M
Cash, Cash Equivalents and Short-Term Investments3.61M3.61M7.61M7.49M5.13M14.53M
Total Debt392.63K392.63K322.85K284.14K154.12K286.33K
Total Liabilities6.16M6.16M5.34M2.51M1.92M1.62M
Stockholders Equity11.23M11.23M14.75M12.82M15.83M26.69M
Cash Flow
Free Cash Flow-3.93M-3.93M-3.74M-3.38M-11.62M-9.86M
Operating Cash Flow-3.74M-3.74M-3.73M-3.26M-11.61M-9.49M
Investing Cash Flow-138.16K-138.16K-2.19M-126.83K-914.20K411.90K
Financing Cash Flow-115.53K-115.53K6.06M5.78M-118.28K14.16M

Nuchev Pty Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.12
Price Trends
50DMA
0.15
Negative
100DMA
0.15
Negative
200DMA
0.16
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
11.92
Positive
STOCH
-11.11
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NUC, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.15, and below the 200-day MA of 0.16, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 11.92 is Positive, neither overbought nor oversold. The STOCH value of -11.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NUC.

Nuchev Pty Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
AU$38.98M-1.65-31.14%-15.07%29.45%
40
Underperform
AU$36.02M-0.241.03%-52.56%
38
Underperform
AU$19.45M-4.79-29.43%102.21%69.47%
38
Underperform
AU$26.76M-4.86-20.54%13.92%36.28%
38
Underperform
AU$7.00M-0.18-184.71%39.53%49.99%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NUC
Nuchev Pty Ltd
0.12
0.00
0.00%
AU:NOU
Noumi Limited
0.13
-0.03
-18.75%
AU:AHF
Australian Dairy Nutritionals Group
0.04
-0.03
-47.76%
AU:WNX
Wellnex Life Ltd
0.09
-0.54
-85.69%
AU:MBH
Maggie Beer Holdings Ltd.
0.09
0.04
80.00%

Nuchev Pty Ltd Corporate Events

Nuchev Limited Announces Successful AGM Results
Nov 28, 2025

Nuchev Limited announced the successful results of its Annual General Meeting, where all resolutions were passed by a poll. This outcome reflects strong shareholder support and may positively impact the company’s governance and strategic direction, reinforcing its position in the nutritional and wellness industry.

Nuchev Limited Outlines Strategic Priorities for Growth
Nov 28, 2025

Nuchev Limited has announced its strategic priorities to enhance its global presence and accelerate innovation. The company plans to strengthen its brand, drive sales growth through improved marketing, and maintain financial strength, which could positively impact its market positioning and stakeholder confidence.

Nuchev Restructures Executive Team for Growth
Nov 6, 2025

Nuchev Limited has restructured its executive team by transitioning the combined COO/CFO role into a standalone CFO position, leading to the departure of Mick Myers. This change is part of Nuchev’s strategy to support its next phase of growth and streamline operations, following significant contributions from Myers in organizational transformation and strategic agreements.

Nuchev Limited Corrects Market Announcement on $2 Million Facility
Nov 5, 2025

Nuchev Limited announced a correction to a previous market announcement regarding a $2 million unsecured facility, initially omitting the parties involved due to administrative oversight. The facility is funded by two major shareholders, 402339 Pty Ltd ATF the Whiti Trust and H&S Global Holdings Pty Ltd ATF the H&S Investment Unit Trust. The company has revised its procedures to enhance transparency and compliance, reflecting its commitment to maintaining stakeholder trust.

Nuchev Limited Issues Unquoted Securities Under Employee Incentive Scheme
Oct 31, 2025

Nuchev Limited announced the issuance of 917,467 unquoted securities under an employee incentive scheme, which are subject to transfer restrictions and will not be quoted on the ASX until these restrictions are lifted. This move is part of the company’s strategy to incentivize its workforce, potentially impacting its operational dynamics and aligning employee interests with long-term company performance.

Nuchev Limited Reaffirms Commitment to Corporate Governance Standards
Oct 31, 2025

Nuchev Limited, a company listed on the ASX under the code NUC, has released its 2025 Corporate Governance Statement, emphasizing its commitment to high standards of corporate governance. The company adheres to the ASX Corporate Governance Principles and Recommendations, ensuring transparency, fair dealing, and stakeholder protection. The statement outlines the company’s governance practices and compliance with the ASX guidelines, highlighting areas where recommendations were not followed and the alternative practices adopted. This approach aims to maintain stakeholder trust and ensure legal compliance.

Nuchev’s 2025 Vision: Leading Global Wellness Transformation
Oct 31, 2025

Nuchev Pty Ltd has released its 2025 Annual Report, emphasizing its vision to become a global leader as a House of Brands focused on transforming wellness, longevity, and quality of life through therapeutic, future-focused solutions. The report outlines the company’s commitment to inspiring healthier and happier futures, with a focus on risk and governance, directors’ and remuneration reports, and financial statements, indicating a strategic approach to enhancing its market position and stakeholder value.

Nuchev Limited Announces 2025 Annual General Meeting
Oct 30, 2025

Nuchev Limited has announced the notice of its 2025 Annual General Meeting, which will be held virtually on November 28, 2025. This meeting is significant for shareholders as it affects their shareholding and voting rights. The company continues to emphasize its commitment to providing high-quality nutritional and wellness products, reflecting its strategic positioning in the industry.

Nuchev Reports Strong Q1 FY26 Revenue Growth Amidst Strategic Market Expansion
Oct 30, 2025

Nuchev Pty Ltd reported a 30% increase in group revenue to $6.5 million for Q1 FY26, driven by strong sales in the ANZ region and successful market entry into Vietnam. The company’s Oli6® Nutritional sales showed significant growth, particularly in China and Vietnam, underscoring the brand’s market strength and strategic distribution partnerships. Despite cash flow challenges due to production costs and timing, Nuchev remains focused on profitability and market expansion through new product development and strategic agreements.

Nuchev Secures $2 Million Working Capital Facility to Boost Growth
Oct 30, 2025

Nuchev Limited has secured a $2 million unsecured Working Capital Facility funded by two substantial shareholders. This facility will enable the company to expedite its growth plans, providing flexibility to explore further expansion opportunities and aim for positive cash flows and profitability in the short to medium term.

Nuchev Limited Announces Change in Share Registry Provider
Sep 9, 2025

Nuchev Limited has announced a change in its shareholder registry services provider, transitioning from Automic Pty Ltd to XCEND Pty Ltd. This change will take effect after market close on October 24, 2025. The move is part of the company’s ongoing efforts to streamline operations and enhance service delivery to stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 20, 2025